No connection

Search Results

AIFF vs YXT

AIFF
Firefly Neuroscience, Inc.
BEARISH
Price
$2.75
Market Cap
$39.1M
Sector
Technology
AI Confidence
85%
YXT
YXT.COM Group Holding Limited
BEARISH
Price
$0.63
Market Cap
$37.4M
Sector
Technology
AI Confidence
95%

Valuation

P/E Ratio
AIFF
--
YXT
--
Forward P/E
AIFF
--
YXT
-38.79
P/B Ratio
AIFF
3.84
YXT
3.54
P/S Ratio
AIFF
49.92
YXT
0.11
EV/EBITDA
AIFF
-3.79
YXT
-1.2

Profitability

Gross Margin
AIFF
65.9%
YXT
68.34%
Operating Margin
AIFF
-632.47%
YXT
-40.88%
Profit Margin
AIFF
0.0%
YXT
-46.71%
ROE
AIFF
-340.82%
YXT
-105.3%
ROA
AIFF
-61.48%
YXT
-13.26%

Growth

Revenue Growth
AIFF
1075.8%
YXT
4.7%
Earnings Growth
AIFF
--
YXT
--

Financial Health

Debt/Equity
AIFF
--
YXT
2.28
Current Ratio
AIFF
2.0
YXT
0.49
Quick Ratio
AIFF
1.66
YXT
0.43

Dividends

Dividend Yield
AIFF
--
YXT
--
Payout Ratio
AIFF
0.0%
YXT
0.0%

AI Verdict

AIFF BEARISH

AIFF exhibits severe financial distress despite strong revenue growth, as reflected in its Piotroski F-Score of 1/9 (indicating poor financial health) and the absence of an Altman Z-Score (implying no safety margin against bankruptcy). The company operates at a massive loss with negative ROE (-340.82%) and operating margin (-632.47%), while trading at an extreme valuation (Price/Sales of 49.92). Although revenue growth is explosive (1075.8% YoY), this is not sustainable without profitability. The stock's recent price surge is likely speculative, not fundamental.

Strengths
Exceptional revenue growth of 1075.8% YoY
High gross margin of 65.90% indicates strong product-level pricing power
Solid current ratio of 2.00 and quick ratio of 1.66 suggest short-term liquidity adequacy
Risks
Piotroski F-Score of 1/9 signals extreme financial instability and operational failure
Negative operating margin (-632.47%) and ROE (-340.82%) indicate severe profitability collapse
No available debt/equity or cash/debt data raises concerns about capital structure transparency
YXT BEARISH

YXT exhibits severe financial distress, highlighted by a weak Piotroski F-Score of 2/9 and a critical liquidity shortage with a Current Ratio of 0.49. The company is plagued by deep negative profitability, including an ROE of -105.30% and a profit margin of -46.71%, while carrying a high Debt/Equity ratio of 2.28. Despite a very low Price/Sales ratio of 0.11, the lack of earnings and chronic long-term value destruction (-93.8% over 5 years) render the stock highly speculative. Recent short-term price spikes appear to be volatility-driven rather than fundamentally supported.

Strengths
Very low Price-to-Sales ratio (0.11)
Strong Gross Margin (68.34%)
Positive YoY revenue growth (4.70%)
Risks
Severe liquidity risk (Current Ratio 0.49)
High leverage (Debt/Equity 2.28)
Extreme capital inefficiency (ROE -105.30%)

Compare Another Pair

AIFF vs YXT: Head-to-Head Comparison

This page compares Firefly Neuroscience, Inc. (AIFF) and YXT.COM Group Holding Limited (YXT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile